Komori
Mitsubishi Chemical Group (4188) · RiskRestated

Unrealized synergies following acquisitions and joint ventures, and restructuring costs

First written in FY2016. 1 of 2 entries say "Restated". Latest entry: FY2019.

2entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2016 – FY20192016: 120162017: 020172018: 020182019: 12019
Same theme, other companies
Risk of underperformance and integration failure in M&A and business restructuringA theme 113 companies write about · 115 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2025: 11 of 40 companies on the "Worse" side.

52 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 113 companies compared. The sentences above are computed from all 113.
Full recordFilings, disclosures and news, newest first
  1. FY2019RestatedAnnual report

    「If business development through mergers, acquisitions, joint ventures and other activities in Japan and overseas aimed at expanding the scale of operations or transforming the business portfolio fails to generate the synergies and other benefits initially expected, or if the associated funding burden or new liabilities and other issues not anticipated by the Group arise or are discovered after a merger, acquisition or other transaction, this may affect business performance. In addition, if the Group undertakes business restructuring, including withdrawing from unprofitable businesses or reorganizing affiliates, as part of its selection and concentration of businesses, this may affect business performance.」

    In addition to unrealized synergies from M&A and joint ventures and the associated funding burden, the company continues to identify the impact of business restructuring as a risk.
  2. FY2016First statedAnnual report

    「Business expansion through mergers, acquisitions, joint ventures and other arrangements in Japan and overseas, undertaken to expand the scale of operations and transform the business portfolio, may affect results if the expected synergies and other benefits are not achieved, or if new liabilities or other problems not anticipated by the group arise or are discovered due to the associated funding burden or after the mergers, acquisitions or other transactions.」

    While positioning M&A and joint ventures as means of achieving growth, the company discloses unrealized synergies, funding burdens, and unforeseen liabilities and other issues as risks.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Mitsubishi Chemical Group yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.